About Julie Grant
Form D filings for Reactive Biosciences from 2022 to 2023 list Julie Grant as chief executive officer and director.
Julie Grant first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Julie Grant in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Julie Grant works with at each company, as listed on that company's latest Form D.
Reactive Biosciences Inc. · Form D, Jun 22, 2023
EB
Esther van den Boom
Executive officer
PF
Peter Farina
Director